Answers are grounded in this paper and cite their sources.
Retinal degeneration, marked by the progressive loss of photoreceptors, is a leading cause of blindness. Photocapacitive biointerfaces provide a prosthesis-style approach to reestablish light-driven neural activity. Here, we present a flexible Cu₂SnS₃ quantum dots/polymer heterojunction (P3HT:PCBM)-based hybrid biointerface that enables wireless photoelectrical stimulation of neurons. The device is forming a stack whose effective capacitance and photocurrent scale with wavelength, emulating retinal spectral sensitivity. When interfaced with neurons, the heterojunction produces red-light-evoked photocurrents (peak ~4.5 nA at 8 mW cm⁻²) and drives measurable changes in both membrane potential and intracellular calcium (ΔF/F₀ increase of ~10%). The operation is non-thermal and remains in the capacitive regime, while the hybrid architecture enhances charge separation and interfacial storage compared with single-material layers. These results define a flexible photocapacitive platform that achieves visible/NIR neuromodulation. Validation on hippocampal neurons and future studies on retinal ganglion cells advance this platform toward prosthetic vision applications.
No takes yet. Share an insight, caveat, or question.
Vanalakar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: